Reports Q2 revenue $55.26B, consensus $54.97B. “We delivered strong second quarter financial results while taking significant strategic and operational actions to position us for future growth,” said Jason Hollar, CEO of Cardinal Health (CAH). “Led by robust demand across our Pharmaceutical and Specialty Solutions segment, we are again pleased to raise our fiscal 2025 enterprise guidance.”
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH: